CCH resulted in the emergence of more NLRP3, LC3 and p62 puncta and fewer LAMP1 puncta, indicating the formation of NLRP3 aggregates, impaired autophagic flux and lysosomal dysfunction, respectively. The gene discussed is MAP1LC3A; the disease is columnar cell hyperplasia of the breast.